Financials

News Discussions Technicals Forecast Seasonals

069620 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to DAEWOONG PHARMACEUTICAL operating, investing, and financing activities

069620 free cash flow for Q2 24 is -47.72 B KRW. For 2023, 069620 free cash flow was 21.67 B KRW and operating cash flow was 131.01 B KRW.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: KRW

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—